Document is current
Any future updates will be listed below
-
Authors
Davis, Rachel H. https://orcid.org/0000-0003-2848-0010
Bryant, Robert V.
Gibson, Peter R. https://orcid.org/0000-0001-9108-1712
Day, Alice S. https://orcid.org/0000-0003-4905-5056
- License Information
-
More Information
Article History
Accepted: 5 January 2026
First Online: 22 January 2026
Competing interests
: R.V.B. has received grant, research support or speaker fees (all paid to his employer for research support) from AbbVie, Ferring, Janssen, Shire, Takeda, GSK and Emerge Health; and is a shareholder in Biomebank. P.R.G. is a consultant or advisory board member for Anatara, Atmo Biosciences, Topas and Comvita; has received research grants for investigator-driven studies from Mindset Health, and speaker honoraria from Dr Falk Pharma and Mindset Health Pty.; and is a shareholder in Atmo Biosciences. His salary is derived from sales of a digital application (Monash University FODMAP diet app), patient booklets cookbooks and online courses, all of which relate to the low FODMAP diet therapy. The other authors declare no competing interests.
